Wuhan General Group (China) Stock

Wuhan General Group (China) Stocks 2024

Wuhan General Group (China) Stocks

32.51 M

Ticker

WUHN

ISIN

US9825691051

WKN

A0M46T

In 2024, Wuhan General Group (China) had 32.51 M outstanding stocks, a 0.74% change from the 32.26 M stocks in the previous year.

The Wuhan General Group (China) Stocks history

YEARNUMBER OF STOCKS (undefined USD)
201232.51
201132.26
201031.89
200937.81
200847.09
200733.63
200613.8
20058.2
20048.2
20038.2

Wuhan General Group (China) shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Wuhan General Group (China) earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Wuhan General Group (China)'s earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Wuhan General Group (China)’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Wuhan General Group (China)'s prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Wuhan General Group (China) Aktienanalyse

What does Wuhan General Group (China) do?

M2bio Sciences Inc is an American biotechnology company based in Phoenix, Arizona. The company was founded in 2018 and has since become one of the largest players in the field of medical research. Their business model focuses on the discovery, development, and commercialization of bio-products and services aimed at improving the health of people worldwide. They offer diagnostic tests, health-promoting bio-products, and therapeutic treatments for chronic diseases such as cancer, Alzheimer's, and diabetes. The company is dedicated to continuous research and development and invests in innovative technologies to improve medical care. Wuhan General Group (China) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Wuhan General Group (China)'s Shares Outstanding

Wuhan General Group (China)'s shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Wuhan General Group (China)’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Wuhan General Group (China)’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Wuhan General Group (China)’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Wuhan General Group (China) stock

How many stocks are there of Wuhan General Group (China)?

The current number of stocks of Wuhan General Group (China) is 32.51 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Wuhan General Group (China) are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Wuhan General Group (China) evolved in recent years?

The number of shares of Wuhan General Group (China) has increased by 0.74% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Wuhan General Group (China) as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Wuhan General Group (China)?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Wuhan General Group (China) pay?

Over the past 12 months, Wuhan General Group (China) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Wuhan General Group (China) is expected to pay a dividend of 0 USD.

What is the dividend yield of Wuhan General Group (China)?

The current dividend yield of Wuhan General Group (China) is .

When does Wuhan General Group (China) pay dividends?

Wuhan General Group (China) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Wuhan General Group (China)?

Wuhan General Group (China) paid dividends every year for the past 0 years.

What is the dividend of Wuhan General Group (China)?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Wuhan General Group (China) located?

Wuhan General Group (China) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Wuhan General Group (China) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Wuhan General Group (China) from 12/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.

When did Wuhan General Group (China) pay the last dividend?

The last dividend was paid out on 12/20/2024.

What was the dividend of Wuhan General Group (China) in the year 2023?

In the year 2023, Wuhan General Group (China) distributed 0 USD as dividends.

In which currency does Wuhan General Group (China) pay out the dividend?

The dividends of Wuhan General Group (China) are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Wuhan General Group (China)

Our stock analysis for Wuhan General Group (China) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wuhan General Group (China) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.